增加跌倒风险的药物:系统综述与荟萃分析之三:其他类药物
该系统综述与荟萃分析纳入281项研究,评估非精神类和非心血管类药物与≥60岁人群跌倒风险的关联。荟萃分析显示阿片类、抗癫痫药及多重用药与跌倒风险显著增加相关,长期使用质子泵抑制剂和阿片类起始治疗可能增加跌倒风险。
要点
- 阿片类、抗癫痫药及多重用药与老年人跌倒风险显著增加相关。
- 长期使用质子泵抑制剂及阿片类起始治疗可能增加跌倒风险。
- 泻药与跌倒的关联不一致,多数荟萃分析存在显著异质性。
核心结论
- 阿片类、抗癫痫药使用及多重用药与老年人跌倒风险增加显著相关。
- 长期使用质子泵抑制剂和阿片类起始治疗可能增加跌倒风险。
- 部分药物类别作为跌倒风险增加药物的因果作用仍不明确。
研究设计与样本
- 系统综述与荟萃分析,检索Medline、PsycINFO和Embase数据库。
- 纳入研究非精神类和非心血管类药物作为跌倒风险因素,对象为≥60岁或平均年龄≥70岁者。
- 定性合成纳入281项研究,荟萃分析采用通用逆方差法,分别合并未调整和调整的OR估计。
主要发现
- 调整数据荟萃分析合并OR(95%CI):阿片类1.60(1.35-1.91)。
- 调整数据荟萃分析合并OR(95%CI):抗癫痫药1.55(1.25-1.92)。
- 调整数据荟萃分析合并OR(95%CI):多重用药1.75(1.27-2.41)。
- 调整数据荟萃分析合并OR(95%CI):镇痛药1.42(0.91-2.23)、NSAIDs 1.09(0.96-1.23)、抗帕金森药1.54(0.99-2.39)。
- 描述性合成中,长期质子泵抑制剂使用和阿片类起始治疗与跌倒呈一致关联,泻药关联不一致(7/20研究显示正关联)。
关键数值与推荐
- 荟萃分析采用调整数据合并OR:阿片类1.60(1.35-1.91)、抗癫痫药1.55(1.25-1.92)、多重用药1.75(1.27-2.41)。
- 镇痛药OR 1.42(0.91-2.23)、NSAIDs OR 1.09(0.96-1.23)、抗帕金森药OR 1.54(0.99-2.39)。
- 多数荟萃分析存在显著异质性,按人群和场所分层后多数未消失。
临床怎么用
- 对老年人处方阿片类、抗癫痫药及多重用药时应评估跌倒风险。
- 长期使用质子泵抑制剂或起始阿片类治疗时需关注跌倒风险。
局限性
- 多数荟萃分析存在显著异质性,按人群和场所分层后多数未消失。
- 部分药物类别作为跌倒风险增加药物的因果作用仍不明确。
- 现有文献存在显著局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: The use of psychotropic medication and cardiovascular medication has been associated with an increased risk of falling. However, other frequently prescribed medication classes are still under debate as potential risk factors for falls in the older population. The aim of this systematic review and meta-analysis is to evaluate the associations between fall risk and nonpsychotropic and noncardiovascular medications. METHODS AND DESIGN: A systematic review and meta-analysis. A search was conducted in Medline, PsycINFO, and Embase. Key search concepts were "falls," "aged," "medication," and "causality." Studies were included that investigated nonpsychotropic and noncardiovascular medications as risk factors for falls in participants ≥60 years or participants with a mean age ≥70 years. A meta-analysis was performed using the generic inverse variance method, pooling unadjusted and adjusted odds ratio (OR) estimates separately. RESULTS: In a qualitative synthesis, 281 studies were included. The results of meta-analysis using adjusted data were as follows (a pooled OR [95% confidence interval]): analgesics, 1.42 (0.91-2.23); nonsteroidal anti-inflammatory drugs (NSAIDs), 1.09 (0.96-1.23); opioids, 1.60 (1.35-1.91); anti-Parkinson drugs, 1.54 (0.99-2.39); antiepileptics, 1.55 (1.25-1.92); and polypharmacy, 1.75 (1.27-2.41). Most of the meta-analyses resulted in substantial heterogeneity that did not disappear after stratification for population and setting in most cases. In a descriptive synthesis, consistent associations with falls were observed for long-term proton pump inhibitor use and opioid initiation. Laxatives showed inconsistent associations with falls (7/20 studies showing a positive association). CONCLUSION: Opioid and antiepileptic use and polypharmacy were significantly associated with increased risk of falling in the meta-analyses. Long-term use of proton pump inhibitors and opioid initiation might increase the fall risk. Future research is necessary because the causal role of some medication classes as fall-risk-increasing drugs remains unclear, and the existing literature contains significant limitations.
引用
- Seppala LJ, van de Glind EMM, Daams JG, et al. Fall-Risk-Increasing Drugs: A Systematic Review and Meta-analysis: III. Others. J Am Med Dir Assoc. 2018. PMID: 29402646. doi:10.1016/j.jamda.2017.12.099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。